Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent E-cadherin expression in inflammatory breast cancer.

C G Kleer1, K L van Golen, T Braun

  • 1Department of Pathology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. kleer@umich.edu

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|May 16, 2001
PubMed
Summary

Inflammatory breast cancer (IBC) uniformly expresses E-cadherin, unlike many non-IBC cases. This finding suggests E-cadherin plays a role in IBC development and progression, challenging previous tumor suppressor theories.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An inflammasome-driven differentiation program in intestinal stem cells protects against Salmonella infection.

Nature immunology·2026
Same author

Direct Experimental Proof of the Principal Role of Reduced High-Mode Hydrodynamic Mix in Recent Ignition Success on NIF.

Physical review letters·2025
Same author

First Demonstration of Improved Fusion Yield with Increased Compression through Reduced Adiabat in Inertial Confinement Fusion Experiments at the National Ignition Facility.

Physical review letters·2025
Same author

Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay.

ESMO open·2025
Same author

Author Correction: Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation.

Scientific reports·2025
Same author

"Optimal timing for RNA isolation: Recommendations for placenta sample collection under clinical conditions".

Placenta·2025

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • E-cadherin is a cell adhesion protein crucial for epithelial tissue integrity.
  • Loss of E-cadherin is often linked to tumor progression and metastasis, suggesting a tumor suppressor role.
  • The function of E-cadherin in inflammatory breast cancer (IBC), a rare and aggressive subtype, remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression patterns of E-cadherin in IBC compared to stage-matched non-IBC.
  • To determine if E-cadherin expression correlates with the development and progression of the IBC phenotype.
  • To explore potential differences in E-cadherin expression between IBC and non-IBC subtypes.

Main Methods:

  • Analysis of 42 breast cancer cases (20 IBC, 22 non-IBC) using strict diagnostic criteria.

Related Experiment Videos

  • Immunohistochemical staining of formalin-fixed, paraffin-embedded tissues for E-cadherin, ER, PR, and HER2/neu.
  • Statistical analysis, including Fisher's exact test, to compare E-cadherin expression between groups.

    • Main Results:

    • All IBC cases (100%) uniformly expressed E-cadherin.
    • A significant majority of non-IBC cases (68%) expressed E-cadherin (P = .006).
    • E-cadherin was strongly expressed in intralymphatic tumor emboli and invasive lobular carcinomas within the IBC cohort. No association was found with ER, PR, or HER2/neu status.

    Conclusions:

    • E-cadherin expression is strongly associated with inflammatory breast cancer, contrary to its typical tumor suppressor role.
    • E-cadherin may be involved in the pathogenesis of IBC, potentially contributing to its aggressive phenotype.
    • Circulating IBC tumor cells exhibit strong E-cadherin expression, representing an exception to the general rule of E-cadherin loss correlating with poor prognosis in breast cancer.